© 2020 MJH Life Sciences™ and . All rights reserved.
HER-2 Predicts Complete Pathologic Response to Chemo Neoadjuvant Chemotherapy
February 1, 2001
The goal of this activity is to clarify challenging treatment issues of HER2+ breast cancer including incorporation of predictive and prognostic biomarker tests and evidence-based data into practice when determining individualized strategies that improve patient survival and quality of life.
Optimal Care for HER2+ Breast Cancer
An interactive case challenge activity.
The goal of this activity is to clarify challenging treatment issues of HER2+ breast cancer including incorporation of predictive and prognostic biomarker tests and evidence-based data into practice when determining individualized strategies that improve patient survival and quality of life.
Go to Activity